Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line
Article in RSC Advances (January 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in RSC Advances (January 2024)
Article in Frontiers in Pharmacology (March 2023)
Article in Current Pharmaceutical Biotechnology (January 2023)